receives approval from the FDA to commence Phase I clinical trials for ProCord for complete Spinal Cord injuries. Jan. 2000 Second round of financing lead by ABS GE Capital Giza Fund... clinical trial for ProCord at Erasme Hospital, Brussels, Belgium. Nov. 2001 Proneuron enters a licensing agreement with Teva Pharmaceuticals Industries Ltd. (Teva) to develop... and commercialize new applications for Teva s Copaxone . Feb. 2002 Proneuron completes patient recruitment in the Phase Ia FDA-regulated clinical trial of ProCord. May. 2002 Prof. Michal...

developed by Diacrin, Inc. Phase I clinical trials are being conducted to test this product in spinal cord injury and focal epilepsy. Trials of a similar product to treat Parkinson s... at the University of Pennsylvania, where clinical trials are being conducted using LBS-Neurons to treat stroke victims. Initial clinical results show the treatment to be safe and beneficial..., and is the only CNS nerve that continuously regenerates in adult mammals. Pilot clinical trials using OEG autografts to treat spinal cord injury patients began recently in Lisbon...

of treatments for spinal cord injuries and other central nervous system (CNS) disorders, today announced it had begun enrolling patients in a phase II clinical trial of ProCord. ProCord... clinical need." Proneuron is privately held and based in Ness Ziona, Israel. The company is currently engaged in several clinical studies in the US, Belgium and Israel, including a trial...Full Story Media Coverage Proneuron Biotechnologies: Treatment for Spinal Cord Injury and other Neurological Disorders Company Technology Therapies Clinical Studies News & Events...

. Having first obtained the approval of the FDA and the Israeli Ministry of Health, Proneuron began the first Phase 1 clinical trial in July 2000 and reached the target recruitment... the technology from Weizmann and have turned the idea into an application. And we're in the process of bringing it to the clinic." The Phase I trials included patients from around... in Colorado and former President of American Spinal Injury Association, has followed the clinical progress of several of the phase one trial subjects. He has also expressed...

CORD TREATMENT TRIALS Israelis who suffer spinal cord injury will be given treatment within 14 days of the accident as part of phase II clinical trials at Sheba Medical Center...Full Story Media Coverage Proneuron Biotechnologies: Treatment for Spinal Cord Injury and other Neurological Disorders Company Technology Therapies Clinical Studies News & Events... has shown that specially treated macrophages promote recovery from SCI. Based on these findings, Proneuron is developing ProCord as a clinical product to treat spinal cord injured...